<DOC>
	<DOCNO>NCT02790710</DOCNO>
	<brief_summary>The study test efficacy propranolol placebo , administer reactivation previously acquire obsessive-compulsive disorder ( OCD ) fear , reduce fear avoidance OCD .</brief_summary>
	<brief_title>Brief Intervention OCD Fears</brief_title>
	<detailed_description>Twenty subject OCD enrol study . Participants complete baseline assessment fear avoidance . Participants randomly assign single dose propranolol 40mg placebo , administer immediately fear reactivation procedure . Primary outcome assessment OCD symptom avoidance behavior behavioral avoidance task 2 week intervention</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Principal Diagnosis ObsessiveCompulsive Disorder History serious psychiatric disorder Current Major Depressive Disorder Women pregnant nursing Current use psychiatric medication Persons plan start another treatment study period Any significant medical condition might increase risk participation use medication might negatively interact propranolol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>propanolol</keyword>
	<keyword>obsessive-compulsive disorder</keyword>
</DOC>